Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Petrominerales Ltd. stock logo
PMG
Petrominerales
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
$0.00
$0.97
$4.56
$16.16M1.38197,338 shs57,700 shs
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
$0.14
$0.14
$0.11
$2.04
$26.65M-0.052.55 million shs14.75 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00%0.00%0.00%0.00%0.00%
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/AN/AN/AN/AN/AN/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Petrominerales Ltd. stock logo
PMG
Petrominerales
0.00
N/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00
N/AN/AN/A
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/AN/AN/AN/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/A$4.95 per shareN/A
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
$892.50M0.03$1.50 per share0.09($5.32) per share-0.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
-$14.27M-$1.21N/AN/AN/AN/A-26.14%-22.74%N/A
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
$85.21M$0.760.180.42N/A8.35%-11.65%7.11%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/AN/AN/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/AN/A
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/A
4.14
4.14
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
N/A
0.48
0.42

Institutional Ownership

CompanyInstitutional Ownership
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
74.38%
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
71.50%

Insider Ownership

CompanyInsider Ownership
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
2.15%
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
1.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Petrominerales Ltd. stock logo
PMG
Petrominerales
N/AN/AN/ANot Optionable
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
1615.84 million15.50 millionNot Optionable
Ultra Petroleum Corp. stock logo
UPL
Ultra Petroleum
151197.38 millionN/AOptionable

Recent News About These Companies

Ultra-deepwater FPSO Achieves First Oil
Ultra Petroleum Corp UPM1
Roblox Ultra Toilet Fight Codes (March 2024)
Japan's Nikkei slips as traders weigh US CPI, expected BOJ pivot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Petrominerales stock logo

Petrominerales TSE:PMG

Petrominerales Ltd. (Petrominerales) is an oil and gas company. The Company is engaged in the exploration, development and production of crude oil in Colombia and Peru. The Company's operations include Deep Llanos, Central Llanos, Neiva, Orito and Heavy oil. Deep Llanos production consists of its Corcel and Guatiquia Blocks. Central Llanos production comes from its Casimena, Castor and Mapache Blocks. On July 24, 2012, Petrominerales acquired 100% interest of Veraz Petroleum Peru S.A.C. (Veraz Peru). In December 2012, Fortress Energy Inc along with Petrominerales acquired Alvopetro S.A. Extracao de Petroleo e Gas Natural (Alvopetro S.A.). The ownership interest in Alvopetro S.A. is 25% Fortress and 75% Petrominerales. In November 2013, Pacific Rubiales Energy Corp acquired Petrominerales Ltd.

Synthetic Biologics stock logo

Synthetic Biologics NYSEAMERICAN:SYN

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11 to treat cancer. It has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Synthetic Biologics, Inc. is headquartered in Rockville, Maryland.

Ultra Petroleum stock logo

Ultra Petroleum NASDAQ:UPL

Ultra Petroleum Corp., an independent oil and gas company, engages in the acquisition, exploration, development, operation, and production of oil and natural gas properties. Its principal business activities are developing its natural gas reserves in the Green River Basin of southwest Wyoming—the Pinedale and Jonah fields. As of December 31, 2018, the company owned interests in approximately 114,000 gross acres in Wyoming. The company was founded in 1979 and is headquartered in Englewood, Colorado.